Sabra Health Care REIT (SBRA) to Release Earnings on Wednesday

Sabra Health Care REIT (NASDAQ:SBRA) is anticipated to issue its quarterly earnings data after the market closes on Wednesday, February 19th. Analysts expect the company to announce earnings of $0.36 per share and revenue of $178.01 million for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Sabra Health Care REIT Stock Performance

NASDAQ SBRA opened at $16.24 on Wednesday. The business’s 50-day simple moving average is $17.09 and its 200-day simple moving average is $17.63. The firm has a market capitalization of $3.84 billion, a P/E ratio of 39.61, a P/E/G ratio of 2.02 and a beta of 1.25. Sabra Health Care REIT has a 1-year low of $13.26 and a 1-year high of $20.03. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16.

Sabra Health Care REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Friday, February 14th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 7.39%. Sabra Health Care REIT’s dividend payout ratio (DPR) is 292.69%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a research report on Tuesday, January 7th. Citizens Jmp raised Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th. Truist Financial cut Sabra Health Care REIT from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $18.00 to $17.00 in a research note on Friday, January 17th. Finally, Mizuho reiterated a “neutral” rating and issued a $20.00 target price on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Three equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $18.86.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.